Hyaluronan: Pharmaceutical Characterization and Drug Delivery

Hyaluronic acid (HA), is a polyanionic polysaccharide that consists of N-acetyl-D-glucosamine and β-glucoronic acid. It is most frequently referred to as hyaluronan because it exists in vivo as a polyanion and not in the protonated acid form. HA is distributed widely in vertebrates and presents as a component of the cell coat of many strains of bacteria. Initially the main functions of HA were believed to be mechanical as it has a protective, structure stabilizing and shock-absorbing role in the body. However, more recently the role of HA in the mediation of physiological functions via interaction with binding proteins and cell surface receptors including morphogenesis, regeneration, wound healing, and tumor invasion, as well as in the dynamic regulation of such interactions on cell signaling and behavior has been documented. The unique viscoelastic nature of hyaluronan along with its biocompatibility and nonimmunogenicity has led to its use in a number of cosmetic, medical, and pharmaceutical applications. More recently, HA has been investigated as a drug delivery agent for ophthalmic, nasal, pulmonary, parenteral, and dermal routes. The purpose of our review is to describe the physical, chemical, and biological properties of native HA together with how it can be produced and assayed along with a detailed analysis of its medical and pharmaceutical applications.

[1]  Lilly Y. W. Bourguignon,et al.  Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.

[2]  K. Kimata,et al.  Mammalian Hyaluronan Synthases , 2002, IUBMB life.

[3]  B. Toole,et al.  Hyaluronan in morphogenesis. , 2001, Journal of internal medicine.

[4]  O. Camber,et al.  Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. , 1989, Current eye research.

[5]  L. Sundblad Chapter 29 – GLYCOSAMINOGLYCANS AND GLYCOPROTEINS IN SYNOVIAL FLUID , 1965 .

[6]  Bin Zhou,et al.  Identification of the Hyaluronan Receptor for Endocytosis (HARE)* , 2000, The Journal of Biological Chemistry.

[7]  T. Yamaguchi,et al.  Molecular weight independence of the effect of additive hyaluronic acid on the lubricating characteristics in synovial joints with experimental deterioration. , 1999, Clinical biomechanics.

[8]  Jennifer G. Smith,et al.  Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses , 1997, The Australasian journal of dermatology.

[9]  A. J. Day,et al.  Hyaluronan-binding Proteins: Tying Up the Giant* , 2002, The Journal of Biological Chemistry.

[10]  M. Jassal,et al.  Use of polysaccharide fibres for modern wound dressings , 2002 .

[11]  S. Gandolfi,et al.  Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  T. Laurent,et al.  Fractionation of hyaluronic acid. The polydispersity of hyaluronic acid from the bovine vitreous body. , 1960, Biochimica et biophysica acta.

[13]  C. McEwen,et al.  Comparison of Most Probable Peak Values As Measured for Polymer Distributions by MALDI Mass Spectrometry and by Size Exclusion Chromatography , 1996 .

[14]  R. Linhardt,et al.  Detection of glycosaminoglycans as a copper(II) complex in high-performance liquid chromatography. , 1997, Journal of chromatography. A.

[15]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[16]  W. Tew,et al.  Relative molecular weight and concentration determination of sodium hyaluronate solutions by gel-exclusion high-performance liquid chromatography. , 1985, Analytical biochemistry.

[17]  A. Spicer,et al.  Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.

[18]  M. Dougados,et al.  A HYALURONAN PREPARATION (500–730 KDA) IN THE TREATMENT OF OSTEOARTHRITIS: A REVIEW OF CLINICAL TRIALS WITH HYALGAN® , 2002, International journal of clinical practice.

[19]  M. Kinoshita,et al.  Hyaluronic acid: separation and biological implications. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  B. Reubinoff,et al.  Hyaluronic acid can successfully replace albumin as the sole macromolecule in a human embryo transfer medium. , 2003, Fertility and sterility.

[21]  R. Jelliffe,et al.  In vitro and in vivo studies with sodium hyaluronate as a carrier for intraocular gentamicin , 1991, Acta ophthalmologica.

[22]  E. Balazs,et al.  Rheology of hyaluronic acid , 1968, Biopolymers.

[23]  D J Berry,et al.  Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Weiliam Chen,et al.  Hyaluronan microspheres for sustained gene delivery and site-specific targeting. , 2004, Biomaterials.

[25]  K. Kubota,et al.  Effects of sodium chloride, guanidine hydrochloride, and sucrose on the viscoelastic properties of sodium hyaluronate solutions , 1999 .

[26]  Robert Gurny,et al.  Design and evaluation of controlled release systems for the eye , 1987 .

[27]  D. Quaglino,et al.  Hyaluronan-phospholipid interactions. , 1997, Journal of structural biology.

[28]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[29]  G. Dutton,et al.  Determination of molecular weight of hyaluronic acid in bovine vitreous humour and Healon by high performance gel permeation chromatography and its depolymerization with ascorbic acid. , 1997, Pharmacy world & science : PWS.

[30]  A. Ogston,et al.  On the state of hyaluronic acid in synovial fluid. , 1950, The Biochemical journal.

[31]  D. Monti,et al.  Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. , 1994, Journal of ocular pharmacology.

[32]  N. Volpi Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine. , 2000, Analytical biochemistry.

[33]  A. Ogston,et al.  The dimensions of the particle of hyaluronic acid complex in synovial fluid. , 1951, The Biochemical journal.

[34]  P. Ghosh,et al.  Interactions of hyaluronan (hyaluronic acid) with phospholipids as determined by gel permeation chromatography, multi-angle laser-light-scattering photometry and 1H-NMR spectroscopy. , 1994, International journal of biological macromolecules.

[35]  A. Trounson,et al.  The effect of extracellular matrix molecules on mouse preimplantation embryo development in vitro. , 2002, Reproduction, fertility, and development.

[36]  J. Kirwan Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? , 2001, The Knee.

[37]  W. Reed,et al.  The effects of pH on hyaluronate as observed by light scattering , 1989, Biopolymers.

[38]  B. Pierscionek,et al.  The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. , 1993, Seminars in arthritis and rheumatism.

[39]  C. Cockerell,et al.  Actinic Keratoses , 1997 .

[40]  Susi Burgalassi,et al.  Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid , 1989 .

[41]  E. Balazs,et al.  Viscosupplementation: a new concept in the treatment of osteoarthritis. , 1993, The Journal of rheumatology. Supplement.

[42]  R. Schwartz The Actinic Keratosis A Perspective and Update , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[43]  S. Goodison,et al.  CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.

[44]  K. Anno,et al.  Improved method for electrophoretic separation and rapid quantitation of isomeric chondroitin sulfates on cellulose acetate strips. , 1970, Analytical biochemistry.

[45]  D. Weinberger,et al.  A comparison of the effect of hyaluronic acid versus gentamicin on corneal epithelial healing , 1998, Eye.

[46]  J. Harris,et al.  Modulation of immunity in cancer patients by prostaglandin antagonists. , 1989, Progress in clinical and biological research.

[47]  C. Marriott,et al.  The effect of hyaluronan on the in vitro deposition of diclofenac within the skin. , 1995, International journal of tissue reactions.

[48]  A. Ogston,et al.  Further observations on the preparation and composition of the hyaluronic acid complex of ox synovial fluid. , 1952, The Biochemical journal.

[49]  B. Yeung,et al.  Molecular weight determination of hyaluronic acid by gel filtration chromatography coupled to matrix-assisted laser desorption ionization mass spectrometry. , 1999, Journal of chromatography. A.

[50]  Effect of lyophilization on the physical characteristics of medium molecular mass hyaluronates , 1994 .

[51]  M. Hochberg Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. , 2000, Seminars in arthritis and rheumatism.

[52]  G. Prestwich,et al.  Hyaluronate derivatives in drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[53]  L. Lebel Clearance of hyaluronan from the circulation , 1991 .

[54]  M. Davies,et al.  Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. , 1996, Free radical biology & medicine.

[55]  B. Blumberg Light-scattering studies on hyaluronic acid. , 1954, Science.

[56]  T. Laurent,et al.  An early look at macromolecular crowding. , 1995, Biophysical chemistry.

[57]  J. Fraser,et al.  Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.

[58]  G. Phillips,et al.  Depolymerization of sodium hyaluronate during freeze drying , 1983 .

[59]  Yoshihiro Ohashi,et al.  Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue , 1991, Pharmaceutical Research.

[60]  J. Scott,et al.  Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  L. R. Abeydeera In vitro production of embryos in swine. , 2002, Theriogenology.

[62]  G. Martin,et al.  An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. , 2001, International journal of pharmaceutics.

[63]  M. Morishita,et al.  Polyion complex of chitosan and sodium hyaluronate as an implant device for insulin delivery , 2003 .

[64]  Diego Guidolin,et al.  Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? , 2002, Seminars in arthritis and rheumatism.

[65]  V. Goldberg,et al.  Osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics. , 2003, Orthopedics.

[66]  M. Klein,et al.  Effects of cryopreservation and deconstruction on the dermal glycosaminoglycan content of human skin. , 1999, Journal of Burn Care and Rehabilitation.

[67]  J. Sheehan,et al.  Effect of the cations sodium, potassium and calcium on the interaction of hyaluronate chains: a light scattering and viscometric study , 1983 .

[68]  D. Ferguson,et al.  Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium* , 2001, The Journal of Biological Chemistry.

[69]  J. Liu,et al.  Thermal Analysis of Semi-Dilute Hyaluronan Solutions , 2000 .

[70]  E. Puré,et al.  The liberation of CD44 , 2003, The Journal of cell biology.

[71]  B. Toole,et al.  Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.

[72]  S. Feldman,et al.  Most common dermatologic problems identified by internists, 1990-1994. , 1998, Archives of internal medicine.

[73]  J. Ortonne,et al.  A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers , 1996 .

[74]  J. Raynauld,et al.  Intra-articular therapy in osteoarthritis , 2003, Postgraduate medical journal.

[75]  E. Suchanek,et al.  Follicular fluid contents of hyaluronic acid, follicle-stimulating hormone and steroids relative to the success of in vitro fertilization of human oocytes. , 1994, Fertility and sterility.

[76]  John E. Scott,et al.  Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. , 2002, Biomacromolecules.

[77]  W. Pigman,et al.  Interactions of hyaluronic acid with serum albumin. , 1961, Biochimica et biophysica acta.

[78]  M. Radice,et al.  Semisynthetic resorbable materials from hyaluronan esterification. , 1998, Biomaterials.

[79]  R. Herberman,et al.  Inhibition of murine natural killer cell activity by prostaglandins. , 1980, Journal of immunology.

[80]  M. Tammi,et al.  Hyaluronan metabolism in skin. , 1994, Progress in histochemistry and cytochemistry.

[81]  H. Greiling,et al.  Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[82]  A. Negi,et al.  [Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits]. , 2002, Nippon Ganka Gakkai zasshi.

[83]  Kozo Takayama,et al.  Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[84]  Jaroslav Drobník,et al.  Hyaluronan in drug delivery , 1991 .

[85]  E. Tschen,et al.  Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses , 2001, International journal of dermatology.

[86]  C. Siebert,et al.  Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis--a prospective clinical trial. , 2002, Osteoarthritis and cartilage.

[87]  W. Pigman,et al.  Preparation and stability of hyaluronic acid. , 1961, Biochimica et biophysica acta.

[88]  S. Granick,et al.  Biolubrication: Hyaluronic Acid and the Influence on Its Interfacial Viscosity of an Antiinflammatory Drug , 2003 .

[89]  C. Katakami,et al.  The effect of hyaluronic acid on corneal epithelial cell proliferation. , 1993, Investigative ophthalmology & visual science.

[90]  J. D. Del Rosso New and emerging topical approaches for actinic keratoses. , 2003, Cutis.

[91]  M. Thibier,et al.  Hyaluronic acid as a substitute for proteins in the deep-freezing of embryos from mice and sheep: An in vitro investigation , 1992 .

[92]  Weiliam Chen,et al.  Characterization of DNA-hyaluronan matrix for sustained gene transfer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[93]  D. Peer,et al.  Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes. , 2000, Archives of biochemistry and biophysics.

[94]  T. Hardingham,et al.  The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association. , 2000, The Biochemical journal.

[95]  O. Ishikawa,et al.  Hyaluronan exists in the normal stratum corneum. , 2000, The Journal of investigative dermatology.

[96]  G. Chow,et al.  CD44-mediated uptake and degradation of hyaluronan. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[97]  A. Hjerpe,et al.  High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[98]  P. Siviero,et al.  Retrospective Study of Outcomes in Hyalgan®-Treated Patients with Osteoarthritis of the Knee , 2002, Clinical drug investigation.

[99]  T. Nakamura,et al.  The effect of sodium hyaluronate on the growth of rabbit corneal epithelial cells in vitro. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[100]  P. Band Hyaluronan Derivatives: Chemistry and Clinical Applications , 1998 .

[101]  A. Okamoto,et al.  Hydrolytic degradation of hyaluronic acid , 1995 .

[102]  G. Karlsson,et al.  Determination of the distribution of molecular masses of sodium hyaluronate by high-performance anion-exchange chromatography. , 2003, Journal of chromatography. A.

[103]  Graham R. Elliott,et al.  Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is inhibited by both prostaglandin E2 and nordihydroguaiaretic acid, a lipoxygenase inhibitor , 2004, Cancer Immunology, Immunotherapy.

[104]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[105]  E. Shimada,et al.  Viscosity and molecular weight of hyaluronic acids. , 1975, Journal of biochemistry.

[106]  W. Hwang,et al.  Effect of glycosaminoglycans on the preimplantation development of embryos derived from in vitro fertilization and somatic cell nuclear transfer. , 2003, Reproduction, fertility, and development.

[107]  H. Maibach,et al.  Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. , 1991, The Journal of investigative dermatology.

[108]  M. Tammi,et al.  Hyaluronan and Homeostasis: A Balancing Act* , 2002, The Journal of Biological Chemistry.

[109]  C. Oner,et al.  Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis , 2003, Clinical Rheumatology.

[110]  I. Koshiishi,et al.  Quantification of hyaluronan and chondroitin/dermatan sulfates in the tissue sections on glass slides. , 1999, Analytical biochemistry.

[111]  G. P. Martin,et al.  Evaluation of the bioadhesive properties of hyaluronan derivatives: Detachment weight and mucociliary transport rate studies , 1996 .

[112]  D. Gardner,et al.  Changing the start temperature and cooling rate in a slow-freezing protocol increases human blastocyst viability. , 2003, Fertility and sterility.

[113]  G. Phillips,et al.  Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution. , 2001, Biopolymers.

[114]  P. Pasche,et al.  Mucosal wound healing after nasal surgery. A controlled clinical trial on the efficacy of hyaluronic acid containing cream. , 1999, Drugs under experimental and clinical research.

[115]  R. Margalit,et al.  Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. , 1998, Archives of biochemistry and biophysics.

[116]  D. Monti,et al.  Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine , 1991 .

[117]  G. Prestwich,et al.  A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. , 2000, Biomacromolecules.

[118]  Karl Meyer,et al.  THE POLYSACCHARIDE OF THE VITREOUS HUMOR , 1934 .

[119]  E. Atkins,et al.  Structure for hyaluronic acid. , 1972, Nature: New biology.

[120]  H. Sasaki,et al.  Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.

[121]  M. Plätzer,et al.  Quantification of hyaluronan in pharmaceutical formulations using high performance capillary electrophoresis and the modified uronic acid carbazole reaction. , 1999, Journal of pharmaceutical and biomedical analysis.

[122]  K. Nishinari,et al.  Effects of the addition of hyaluronate segments with different chain lengths on the viscoelasticity of hyaluronic acid solutions. , 1996, Biopolymers.

[123]  H. Katsumata,et al.  Effects of Low-Viscosity Sodium Hyaluronate Preparation on the Pulmonary Absorption of rh-Insulin in Rats , 2001, Drug development and industrial pharmacy.

[124]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.

[125]  K. Langer,et al.  Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part III: Evaluation as drug delivery system for ophthalmic applications , 1997 .

[126]  H. C. Robinson,et al.  The extracellular processing and catabolism of hyaluronan in cultured adult articular cartilage explants. , 1992, Archives of biochemistry and biophysics.

[127]  D. Guidolin,et al.  Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. , 2001, Osteoarthritis and cartilage.

[128]  K. Arnold,et al.  Molecular dynamics study of hyaluronic acid in water , 1998 .

[129]  K. Lowry,et al.  Thermal stability of sodium hyaluronate in aqueous solution. , 1994, Journal of Biomedical Materials Research.

[130]  R. Moy Clinical presentation of actinic keratoses and squamous cell carcinoma. , 2000, Journal of the American Academy of Dermatology.

[131]  B. Risberg Adhesions: preventive strategies. , 1997, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[132]  U. Chakravarthy,et al.  Quantitative analysis of hyaluronan in vitreous humor using capillary electrophoresis , 1994, Electrophoresis.

[133]  D J Berry,et al.  In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. , 2002, International journal of pharmaceutics.

[134]  R. Wüthrich The proinflammatory role of hyaluronan-CD44 interactions in renal injury. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[135]  K. Nishinari,et al.  Viscoelasticity of hyaluronic acid with different molecular weights. , 1994, Biorheology.

[136]  O. Fennema,et al.  Linear Rate of Water Crystallization as Influenced by Temperature of Hydrocolloid Suspensions , 1987 .

[137]  W. Reed,et al.  Light scattering power of randomly cut random coils with application to the determination of depolymerization rates , 1989 .

[138]  Stefaan De Smedt,et al.  HYALURONAN : PREPARATION, STRUCTURE, PROPERTIES, AND APPLICATIONS , 1998 .

[139]  D. Gardner,et al.  Cryo‐survival and development of bovine blastocysts are enhanced by culture with recombinant albumin and hyaluronan , 2003, Molecular reproduction and development.

[140]  G. Turino,et al.  Hyaluronan in respiratory injury and repair. , 2003, American journal of respiratory and critical care medicine.

[141]  F. Maccari,et al.  Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains‐All , 2002, Electrophoresis.

[142]  C. Milne Fetal development. , 1989, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[143]  M. Cowman,et al.  An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. , 1994, Analytical biochemistry.

[144]  M. Dougados,et al.  Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. , 2000, Seminars in arthritis and rheumatism.

[145]  J. Scott The periphery of the developing collagen fibril. Quantitative relationships with dermatan sulphate and other surface-associated species. , 1984, The Biochemical journal.

[146]  T. Miyano,et al.  Effects of hyaluronic acid on the development of 1- and 2-cell porcine embryos to the blastocyst stage in vitro. , 1994, Theriogenology.

[147]  L. Moreland Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action , 2003, Arthritis research & therapy.

[148]  R. Linhardt,et al.  Conductivity detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans separated by high-performance size-exclusion chromatography. , 2002, Journal of chromatography. A.

[149]  R. Mendichi,et al.  Characterization of ultra-high molar mass hyaluronan: 1. Off-line static methods , 1998 .

[150]  G. Norstedt,et al.  Evaluation of hyaluronan as a vehicle for peptide growth factors , 1992 .

[151]  E. Balazs,et al.  On the limiting viscosity number of hyaluronate in potassium phosphate buffers between pH 6.5 and 8 , 1983 .

[152]  J. Sheehan,et al.  Hyaluronan: polysaccharide chaos to protein organisation. , 2001, Current opinion in structural biology.

[153]  G. Varigos,et al.  Topical diclofenac in hyaluronan gel for the treatment of solar keratoses , 2003, The Australasian journal of dermatology.

[154]  G. Turino,et al.  Aerosolized Hyaluronic Acid Decreases Alveolar Injury Induced by Human Neutrophil Elastase , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[155]  E. Balazs,et al.  Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.

[156]  B. Delpech,et al.  An improved assay for the N-acetyl-D-glucosamine reducing ends of polysaccharides in the presence of proteins. , 2001, Analytical biochemistry.

[157]  I. Kellaway,et al.  Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye , 1995 .

[158]  Yuji Inada,et al.  Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate , 2004, Glycoconjugate Journal.

[159]  K Surendrakumar,et al.  Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[160]  C. Furnus,et al.  Effect of hyaluronic acid on development of in vitro produced bovine embryos. , 1998, Theriogenology.

[161]  P. Mooar,et al.  Intra-articular hyaluronans: a review of product-specific safety profiles. , 2003, Seminars in arthritis and rheumatism.

[162]  J. Demeester,et al.  Absolute and empirical determination of the enzymatic activity and kinetic investigation of the action of hyaluronidase on hyaluronan using viscosimetry. , 1995, The Biochemical journal.

[163]  L. Šoltés,et al.  Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid , 2002, Inflammation Research.

[164]  D. Figgitt,et al.  Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel , 2003, American journal of clinical dermatology.

[165]  S. Arnott,et al.  Hyaluronic acid double helix. , 1983, Journal of molecular biology.

[166]  E. Menzel,et al.  Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. , 1998, Cancer letters.

[167]  J. Peyron,et al.  A Risk-Benefit Assessment of Injections of Hyaluronan and its Derivatives in the Treatment of Osteoarthritis of the Knee , 2000, Drug safety.

[168]  C. Bucolo,et al.  Pharmacological Evaluation of a New Timolol/Pilocarpine Formulation , 1998, Ophthalmic Research.

[169]  Dan Peer,et al.  Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes. , 2003, Biochimica et biophysica acta.

[170]  W. Panje Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. , 1981, Archives of otolaryngology.

[171]  L. Juhlin Hyaluronan in skin , 1997, Journal of internal medicine.

[172]  J. Kreider,et al.  Anionic polysaccharide production and tyrosinase activation in cultured human melanoma cells. , 1976, Cancer research.

[173]  Shayn E Armstrong,et al.  Measurement of high-molecular-weight hyaluronan in solid tissue using agarose gel electrophoresis. , 2002, Analytical biochemistry.

[174]  T. Imanari,et al.  Sensitive detection of unsaturated disaccharides from chondroitin sulphates by thin-layer chromatography as their dansylhydrazine derivatives. , 1989, Journal of chromatography.

[175]  R. Gurny,et al.  Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits. , 1987, Current eye research.

[176]  H. Rodríguez-Martínez,et al.  Effects of sperm treatments on the in vitro development of bovine oocytes in semidefined and defined media. , 1997, Theriogenology.

[177]  J. Gergely,et al.  Light scattering studies on hyaluronic acid. , 1955, The Journal of biological chemistry.

[178]  R. Altman Intra-articular sodium hyaluronate in osteoarthritis of the knee. , 2000, Seminars in arthritis and rheumatism.

[179]  T. Masada,et al.  Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.

[180]  M. How,et al.  Separation and fractionation of hyaluronic acid from human synovial fluid on agarose gels. , 1969, Clinica chimica acta; international journal of clinical chemistry.

[181]  R. Margalit,et al.  Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. , 1994, Archives of biochemistry and biophysics.

[182]  R. Jelliffe,et al.  Sodium hyaluronate as a carrier for intravitreal gentamicin an experimental study , 1991, Acta ophthalmologica.

[183]  John L. Wang,et al.  Ionic polysaccharides. III. Dilute solution properties of hyaluronic acid fractions , 1970, Biopolymers.

[184]  T. Miyano,et al.  Effects of glycosaminoglycans on the development of in vitro-matured and -fertilized porcine oocytes to the blastocyst stage in vitro. , 1998, Biology of reproduction.

[185]  P. Müller,et al.  Specific degradation of hyaluronic acid and its rheological properties , 1998 .

[186]  T. Hardingham,et al.  The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. , 1999, Biophysical journal.

[187]  E. Balazs Analgesic Effect of Elastoviscous Hyaluronan Solutions and the Treatment of Arthritic Pain , 2003, Cells Tissues Organs.

[188]  D. Alcorn,et al.  Absorption of hyaluronan applied to the surface of intact skin. , 1999, The Journal of investigative dermatology.

[189]  W. Fetter,et al.  The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnancies. , 1991, American journal of obstetrics and gynecology.

[190]  T. Laurent,et al.  Catabolism of hyaluronan , 1998 .

[191]  D. Gardner,et al.  Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. , 1999, Human reproduction.

[192]  K. Ebert,et al.  Ultrasonic degradation of polymers in solution , 1977 .

[193]  M. Tammi,et al.  Hyaluronan-Cell Interactions in Cancer and Vascular Disease* , 2002, The Journal of Biological Chemistry.

[194]  C. Yomota,et al.  Hyaluronate depolymerization following thermal decomposition of oxytetracycline. , 2001, Chemical & pharmaceutical bulletin.

[195]  H. Melville,et al.  The ultrasonic degradation of polymers , 1950 .

[196]  A. Okamoto,et al.  Degradation of hyaluronic acid during freeze drying , 1997 .

[197]  A. Spicer,et al.  Mammalian hyaluronan synthases: investigation of functional relationships in vivo. , 1999, Biochemical Society transactions.

[198]  G. P. Martin,et al.  THE USE OF HYALURONAN IN TOPICAL DRUG DELIVERY , 2002 .

[199]  G Mautone,et al.  Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. , 2002, Drugs under experimental and clinical research.

[200]  D. Armstrong,et al.  Outcomes of hyaluronan therapy in diabetic foot wounds. , 2003, Diabetes research and clinical practice.

[201]  E. Balazs,et al.  Drug delivery systems using hyaluronan and its derivatives , 1991 .

[202]  C. Balch,et al.  Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. , 1982, Surgery.

[203]  R. Gurny,et al.  Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.

[204]  R. Herrero-Vanrell,et al.  Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[205]  I. Kaur,et al.  Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery , 2002, Drug development and industrial pharmacy.

[206]  F. Szoka,et al.  Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. , 2001, Cancer research.

[207]  G. Prestwich,et al.  Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. , 1999, Bioconjugate chemistry.